Thiopurine Enhanced Mutations for PD-1/Ligand-1 Efficacy
NCT05276284
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
18
Enrollment
OTHER
Sponsor class
Conditions
Solid Tumor, Adult
Metastatic Cancer
Interventions
COMBINATION_PRODUCT:
Atezolizumab, 6-mercaptopurine, 6-thioguanine
Sponsor
Kristoffer Rohrberg